Verrica Pharmaceuticals (VRCA) Other financing activities (2018 - 2024)
Verrica Pharmaceuticals (VRCA) posted quarterly Other financing activities of $1000.0 for Q4 2024, down 99.33% quarter-over-quarter from $150000.0 in Q2 2024.
Verrica Pharmaceuticals (VRCA) Other financing activities (2018 - 2024) Analysis & Trends
Verrica Pharmaceuticals' Other financing activities history runs 6 years deep, the most recent figure standing at $1000.0 for Q4 2024.
- In Q4 2024, Other financing activities changed N/A year-over-year to $1000.0; the TTM figure through Sep 2025 stood at $1000.0 (down 99.35% YoY), while the FY2024 annual figure was $155000.0, up 2114.29% from the prior year.
- Other financing activities for Q4 2024 stood at $1000.0, down from $150000.0 in the prior quarter.
- The five-year high for Other financing activities was $446000.0 in Q4 2020, with the low at $1000.0 in Q4 2024.
- The 4-year median for Other financing activities is $45000.0 (2021), against an average of $130333.3.
- The sharpest annual moves came in 2021 and 2024: Other financing activities jumped 3328.57% in 2021, then sank 42.86% in 2024.
- Verrica Pharmaceuticals' Other financing activities stood at $446000.0 in 2020, then tumbled by 89.91% to $45000.0 in 2021, then sank by 84.44% to $7000.0 in 2023, then sank by 85.71% to $1000.0 in 2024.
- Business Quant data shows VRCA's Other financing activities at $1000.0 in Q4 2024, $150000.0 in Q2 2024, and $4000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Verrica Pharmaceuticals | 102.80 Mn | 91.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Sep 30, 2021 | 45,000.00 |
| Sep 30, 2021 | 45,000.00 |
| Jun 30, 2021 | 273,000.00 |
| Jun 30, 2021 | 273,000.00 |
| Mar 31, 2021 | 240,000.00 |
| Mar 31, 2021 | 240,000.00 |
| Dec 31, 2020 | 446,000.00 |
| Dec 31, 2020 | 446,000.00 |
| Mar 31, 2020 | 7,000.00 |
| Mar 31, 2020 | 7,000.00 |
| Dec 31, 2019 | 204,000.00 |
| Dec 31, 2019 | 204,000.00 |